SUMMARY A necropsy study of 159 elderly patients drawn mainly from a prospectively assessed geriatric hospital population was carried out to investigate the relationship of cerebral amyloid angiopathy to Alzheimer's disease, other CNS disease and ageing. About half the patients were demented and the majority of these had Alzheimer's disease. In Alzheimer's disease there was an incidence of cerebral amyloid angiopathy of 82%. Among the other groups of patients, both demented and non-demented, the incidence of cerebral amyloid angiopathy was a little over 30%, and remained constant between 60 and 102 years of age.
Materials and methods
Cases studied A total of 159 cases was studied. In all except 10 cases a simple formal assessment of mental state was carried out in the 6 months before death using the Kew test'7 or Mental Test Score.'8 On the basis of clinical findings and the performance on these tests 82 of these patients were found to be demented and 67 non-demented. Ten patients were assessed clinically and of these four were judged to be demented and six undemented. Neuropathology A full necropsy was carried out in all cases and the brain fixed by suspension in 10% neutral formalin for at least 4 weeks. In some cases one cerebral hemisphere was removed before fixation and stored at -70°C for separate biochemical studies. All histological studies were performed on blocks from one fixed cerebral hemisphere. Paraffin blocks were taken from each of the main cerebral lobes and hippocampus from the first 73 cases in the series and from frontal and temporal lobes and hippocampus only from the succeeding 86 cases. The sections examined were from the following areas: superior and middle frontal gyri (Brodmann areas 9 and 46), superior and middle temporal gyri (Brodmann areas 22 (2) Location of cerebral amyloid angiopathy The location of cerebral amyloid angiopathy in all categories of patients was similar. Congophilic change, in the mildest form, affected small patches of the media of small arteries. These patches appeared as incomplete segments in transversely sectioned vessels. In longitudinal sections short lengths of the vessel wall were seen to be affected. When it was a little more advanced the adventitia was also infiltrated by congophilic material and the whole vessel circumference was involved. The full thickness of the vessel wall was affected in the most severe cases. Among the leptomeningeal vessels there was a subjective impression that cerebral amyloid angiopathy was found more commonly at the depths of sulci than at the crowns of gyri, but we are not certain whether this observation was simply a reflection of the greater density of vessels in sulci or whether it represents an increased frequency of cerebral amyloid angiopathy in sulcal vessels. No regular predilection for involvement of leptomeningeal or cortical vessels was observed. Vessels in subcortical and deep white matter were invariably spared. Basal ganglia and brain stem, in the few cases in which they were examined histologically for amyloid, did not show cerebral amyloid angiopathy, but the cerebellar leptomeningeal and cortical vessels were noted to be involved in some cases. There were only slight and insignificant differences in incidence of cerebral amyloid angiopathy between the main cerebral lobes when this was examined in cases from Cerebral amyloid angiopathy in dementia and old age It remains tantalisingly difficult to develop a comprehensive hypothesis to explain the relationship of cerebral amyloid angiopathy to Alzheimer's disease. Glenner20 takes the view that "cerebrovascular amyloidosis is a significant if not the most significant lesion in Alzheimer's disease", and claims that his findings "strongly support a vascular basis for the other lesions in Alzheimer's disease". This view is difficult to reconcile with the regular finding in several studies already referred to, in addition to our own, of a small proportion of Alzheimer's disease patients that lacks cerebral amyloid angiopathy, and of a sizeable minority of undemented patients without Alzheimer's disease pathology who show it. Possibly there is a primary alteration which remains undefined and which in most instances, but not all, gives rise to both cerebral amyloid angiopathy and Alzheimer's disease. Results of pathological studies to date, including the present one, seem more compatible with the view that vascular amyloid is derived from a neural source within the brain and is a consequence of pathological processes going on there rather than the primary cause of those changes. If amyloidcontaining senile plaques reflect abnormal alterations of axonal terminals in the cerebral cortex it seems reasonable to wonder if vascular amyloid reflects abnormalities in nerve terminals innervating leptomeningeal and cortical blood vessels. The detection of neurofilament antigents in the amyloid deposits in cerebral amyloid angiopathy26 lends support to this view. It also seems likely that cerebral amyloid angiopathy has several causes of which one is Alzheimer's disease or the process that gives rise to Alzheimer's disease, and another is y trace protein deposition as seen in the Icelandic familial cases.27 It will be important to search for abnormal proteins in serum and CSF as well as in the cerebral vessels in cases of Alzheimer's disease with cerebral amyloid angiopathy if an analogy can be drawn with familial Icelandic cerebral amyloid angiopathy in which abnormal y trace protein levels in CSF have recently been reported.28
